Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-499
Closed -$7K 1379
2025
Q3
$7K Hold
499
﹤0.01% 1181
2025
Q2
$5K Hold
499
﹤0.01% 1156
2025
Q1
$4K Buy
499
+155
+45% +$1.35K ﹤0.01% 1145
2024
Q4
$3K Hold
344
﹤0.01% 1193
2024
Q3
$3K Hold
344
﹤0.01% 1198
2024
Q2
$3K Hold
344
﹤0.01% 1225
2024
Q1
$4K Buy
344
+157
+84% +$1.74K ﹤0.01% 1219
2023
Q4
$2K Hold
187
﹤0.01% 1271
2023
Q3
$3K Hold
187
﹤0.01% 1195
2023
Q2
$4K Hold
187
﹤0.01% 1195
2023
Q1
$3K Hold
187
﹤0.01% 1184
2022
Q4
$2K Buy
+187
New +$1.68K ﹤0.01% 1222

Other funds holding ETNB

Daiwa Securities Group's ETNB Position: Q4 2025 in Review

Daiwa Securities Group sold out of 89bio (ETNB) in Q4 2025, closing a stake of 499 shares — an estimated $7K sold.

Daiwa Securities Group first reported a position in ETNB in Q4 2022 and held it in 12 quarters. The position peaked at $7K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Daiwa Securities Group reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Daiwa Securities Group sold 499 89bio shares in Q4 2025, an estimated $7K.
  • Daiwa Securities Group first reported a position in 89bio in Q4 2022 and held it in 12 quarters.
  • Daiwa Securities Group's 89bio position peaked at $7K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.